Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Biosci Biotechnol Biochem ; 84(1): 171-177, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31476130

RESUMEN

We tested the hypothesis that α-lactalbumin inhibits the disruption of intestinal barrier function and liver cirrhosis by restoring gut-liver axis function in thioacetamide (TAA) -treated rats. Rat diets were supplemented with α-lactalbumin replacing 50% of dietary protein. After consuming α-lactalbumin for one week, rats were intraperitoneally injected with TAA twice a week for 14 weeks. The α-lactalbumin-enriched diet significantly inhibited the elevation of plasma alanine aminotransferase, aspartate aminotransferase, and hyaluronic acids. The supplement significantly reduced plasma lipopolysaccharide levels and increased occludin mRNA level. Hepatic fibrosis and regenerative nodules was developed and intestinal villi were shortened by TAA; α-Lactalbumin attenuated these histopathological changes. These results indicated that α-lactalbumin improved intestinal barrier function, suppressing endotoxin levels. These data also suggested that α-lactalbumin ameliorated the impairment of the gut-liver axis by TAA, inhibiting the development of liver cirrhosis.


Asunto(s)
Suplementos Dietéticos , Tracto Gastrointestinal/efectos de los fármacos , Lactalbúmina/uso terapéutico , Cirrosis Hepática Experimental/inducido químicamente , Cirrosis Hepática Experimental/dietoterapia , Hígado/efectos de los fármacos , Sustancias Protectoras/uso terapéutico , Tioacetamida/farmacología , Alanina Transaminasa/sangre , Animales , Aspartato Aminotransferasas/sangre , Fibrosis/tratamiento farmacológico , Tracto Gastrointestinal/metabolismo , Expresión Génica/efectos de los fármacos , Ácido Hialurónico/sangre , Inyecciones Intraperitoneales , Lipopolisacáridos/sangre , Hígado/metabolismo , Hígado/patología , Cirrosis Hepática Experimental/prevención & control , Masculino , ARN Mensajero/genética , Ratas , Ratas Sprague-Dawley , Tioacetamida/administración & dosificación , Proteínas de Uniones Estrechas/genética
2.
Int J Mol Sci ; 16(12): 27988-8000, 2015 Nov 25.
Artículo en Inglés | MEDLINE | ID: mdl-26602917

RESUMEN

Despite advances in stem cell biology, there are few effective techniques to promote the osteogenic differentiation of human primary dedifferentiated fat (DFAT) cells. We attempted to investigate whether epigallocatechin-3-gallate (EGCG), the main component of green tea catechin, facilitates early osteogenic differentiation and mineralization on DFAT cells in vitro. DFAT cells were treated with EGCG (1.25-10 µM) in osteogenic medium (OM) with or without 100 nM dexamethasone (Dex) for 12 days (hereafter two osteogenic media were designated as OM(Dex) and OM). Supplementation of 1.25 µM EGCG to both the media effectively increased the mRNA expression of collagen 1 (COL1A1) and runt-related transcription factor 2 (RUNX2) and also increased proliferation and mineralization. Compared to OM(Dex) with EGCG, OM with EGCG induced earlier expression for COL1A1 and RUNX2 at day 1 and higher mineralization level at day 12. OM(Dex) with 10 µM EGCG remarkably hampered the proliferation of the DFAT cells. These results suggest that OM(without Dex) with EGCG might be a preferable medium to promote proliferation and to induce osteoblast differentiation of DFAT cells. Our findings provide an insight for the combinatory use of EGCG and DFAT cells for bone regeneration and stem cell-based therapy.


Asunto(s)
Adipocitos/citología , Adipocitos/efectos de los fármacos , Catequina/farmacología , Desdiferenciación Celular/efectos de los fármacos , Osteogénesis/efectos de los fármacos , Té/química , Fosfatasa Alcalina/metabolismo , Biomarcadores , Calcificación Fisiológica/efectos de los fármacos , Catequina/análogos & derivados , Catequina/química , Proliferación Celular , Células Cultivadas , Expresión Génica , Humanos , Osteoblastos/citología , Osteoblastos/efectos de los fármacos , Osteoblastos/metabolismo , Osteogénesis/genética , ARN Mensajero/genética
3.
Masui ; 51(2): 134-9, 2002 Feb.
Artículo en Japonés | MEDLINE | ID: mdl-11889778

RESUMEN

We examined the effect of acupuncture or electro-acupuncture on circulatory parameters by use of a non-invasive procedure in 10 healthy male adult volunteers. Circulatory parameters measured were systolic blood pressure, pulse rate, total peripheral resistance and cardiac output. Acupuncture and electro-acupuncture significantly increased total peripheral resistance, and electro-acupuncture increased systolic blood pressure further. There was no difference in cardiac output compared with the control. The results suggest that acupuncture or electro-acupuncture has an action of alpha-stimulation but not of beta-stimulation, and that electro-acupuncture has a stronger effect than acupuncture alone.


Asunto(s)
Acupuntura , Presión Sanguínea , Electroacupuntura , Sistema Nervioso Simpático/fisiología , Resistencia Vascular , Adulto , Vasos Sanguíneos/inervación , Gasto Cardíaco , Humanos , Masculino , Pulso Arterial
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA